Adapting to Newer Hemostatic Agent Emicizumab for Major Surgery in Hemophilia A: An Experience in Neurosurgery for an Infant
Malavika Prakash P, Nimsha Rajesh, Narmadha MP, Suhas Udayakumaran & Rema G · Asian Hematology Research Journal · 2025
Background: Perioperative hemostasis for major surgery in Hemophilia A has been cumbersome with clotting factor concentrate (CFC) administration based on half-life and factor activity to minimize fluctuation. Availability of newer agents like FVIII mimetic Emicizumab with steady...
Open access
Research Article
10.9734/ahrj/2025/v8i3202